GC Medical Science Q3 Operating Profit Rises 20.4% Year on Year

• GC Medical Science posted a third-quarter 2026 net loss of 1.51 billion won, versus a year-earlier profit of 1.44 billion won.
• Operating profit rose 20.4% year over year to 1.14 billion won.
• Revenue increased 2.3% from a year earlier to 27.05 billion won.
• For January–September 2026, revenue fell 6.8% to 77.71 billion won.
• The nine-month net loss totaled 5.31 billion won, compared with a year-earlier profit of 3.13 billion won.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GC Medical Science Corp, published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030900795), on October 30, 2026, and is solely responsible for the information contained therein.